Skip to main content

In vitro diagnostics

Digitalised and personalised in vitro diagnostics for an ageing population.


What issue is the project tackling?

We want to give elderly people with reduced mobility access to needs-oriented diagnostics and drug therapy.

What results and impacts is the project aiming to achieve?

Our project uses the in vitro diagnostic cycle, whereby the Spitex nurse, the doctor from eedoctors, the pharmacist and the postal courier all provide interlocking services for elderly people with limited mobility in a timely and decentralised manner.

Customer journey

We create a customer journey (the patient's touch and contact points), representing the path of the patient and/or Spitex staff in the course of the entire diagnostic process. This journey serves both as a means of integration into our application partners' existing processes and as a means of communicating the new service to users and/or customers. The underlying service model is intended to show the activities, responsibilities and processes performed by those participating in the various steps of the diagnostic cycle. In addition, it helps the interdisciplinary project partners develop appropriate services.

In vitro diagnostic test panels

The focus is on the development of rapid tests for the diagnosis of fatigue and infection. It is possible to provide a proof of concept for individual tests as part of the project.

Data flow

There are currently two types of data flow: health-relevant data, and administrative and notification data. The first variant sees the electronic patient dossier EPD play a central role. This central role assumes that the EPD is implemented in such a way that selected persons are notified by email or SMS text message when new documents are received, in the same way that it registers incoming e-banking or SMS documents. No security-relevant data is transmitted.

In the second variant, the EPD plays a subordinate role: the participants communicate directly with each other and exchange both administrative and health data without the EPD. This occurs in conjunction with a business-to-business (B2B) solution, which is expected to be faster to implement. This type of communication is preferred by the partners involved.

The results in variant 1 are:

A mobile app for trained Spitex staff for

  • Exchanging data between the analysis and mobile devices
  • Receiving and displaying EPD notifications
  • Managing/displaying the data flow and information on the flow of goods (incl. prescription)
  • Data flow when issuing and collecting prescriptions via the mobile app
  • Managing the flow of goods (medicines)

The result in variant 2 is:

  • A software library incorporated into existing mobile applications facilitating the exchange of data between various analysis devices and a mobile device

What distinguishes the interdisciplinary collaboration in the project?

Our project boosts expertise in interdisciplinary collaboration at the FHNW by way of the following measures:

  • The project objective – to provide healthcare professionals with tools and methods for the timely diagnosis and medical treatment of people with limited mobility – will only be realised if the existing expertise across the various disciplines of the four participating FHNW Schools (Applied Psychology, Life Sciences, Business, and Engineering) and external project partners (Spitex, nursing homes, eedoctors, Dropa, the postal service, Stammgemeinschaft communities and MIDATA) is pooled throughout the project.
  • The project is divided into work packages with different emphases (technical, user-oriented, economic) that are closely interwoven in terms of their contribution to a comprehensive solution. The work packages will be defined and carried out together with the internal and external project partners.
  • Various meetings and workshops (e.g. "ideation", user scenario and prototyping workshops) are scheduled to ensure that the solutions are truly interdisciplinary.
  • What is more, “reflection days” will be held to record and reflect on the interdisciplinary collaboration itself. The intention is to translate the learnings and insights from these sessions into specific guidelines for university-wide (student) projects.
  • The project results and learnings will be published in reports or other publications.


Prof. Dr. Daniel Gygax
Research Bioanalytics & in-vitro Diagnostics

T +41 61 228 55 79 (direct)          ZGFuaWVsLmd5Z2F4QGZobncuY2g=

Share this page: